MYX 3.29% $4.40 mayne pharma group limited

Price Prediction, page-4

  1. 6,555 Posts.
    lightbulb Created with Sketch. 12
    From today's announcement
    "Currently, Mayne Pharma has more than 35 generic and branded drug products in development targeting US markets with IMS sales greater than US$6.5 billion. Mayne Pharma expects further product launches over the coming year with 12 drug applications pending at the FDA."

    cheers
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.